Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceuticals
Pharma
Hefty sales of generics boost Teva to another big quarter
Teva revealed booming third-quarter sales for its generics, with U.S. revenue from the knockoffs reaching $1.1 billion, which was a 30% increase.
Kevin Dunleavy
Nov 6, 2024 3:19pm
Teva to pay $450M to settle longstanding kickback allegations
Oct 11, 2024 9:23am
DEA raises production quota on Takeda's Vyvanse and its generics
Sep 4, 2024 3:24pm
FTC targets Novo's Ozempic among 300-plus 'junk' patents
May 1, 2024 7:30am
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
Pfizer ponies up $39M to resolve old pay-for-delay lawsuit
Apr 11, 2024 11:00am
